NM_000208.4(INSR):c.3164C>T (p.Ala1055Val) AND none provided

Clinical significance:Likely pathogenic (Last evaluated: Aug 28, 2019)

Review status:1 star out of maximum of 4 stars

criteria provided, single submitter

Based on:
1 submission [Details]
Record status:

Allele description [Variation Report for NM_000208.4(INSR):c.3164C>T (p.Ala1055Val)]

NM_000208.4(INSR):c.3164C>T (p.Ala1055Val)

INSR:insulin receptor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Genomic location:
Preferred name:
NM_000208.4(INSR):c.3164C>T (p.Ala1055Val)
  • NC_000019.10:g.7125377G>A
  • NG_008852.2:g.173624C>T
  • NM_000208.4:c.3164C>TMANE SELECT
  • NM_001079817.3:c.3128C>T
  • NP_000199.2:p.Ala1055Val
  • NP_001073285.1:p.Ala1043Val
  • NC_000019.9:g.7125388G>A
Protein change:
dbSNP: rs1599874183
NCBI 1000 Genomes Browser:
Molecular consequence:
  • NM_000208.4:c.3164C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001079817.3:c.3128C>T - missense variant - [Sequence Ontology: SO:0001583]


none provided
MedGen: CN235283

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
SCV001160653ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratoriescriteria provided, single submitter
Likely pathogenic
(Aug 28, 2019)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories, SCV001160653.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided


The INSR c.3164C>T; p.Ala1055Val variant, also known in alternative nomenclature as p.Ala1028Val, is reported in the literature in several individuals affected with type A insulin resistance and Rabson-Mendenhall syndrome (Jiang 2011, Rique 2000). Parental testing of one affected individuals with this variant indicated it occurred de novo (Jiang 2011), while the other affected individual had relatives found to carry this variant who had high serum insulin levels (Rique 2000). This variant is absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. Functional studies in cultured cells suggest that the p.Ala1055Val protein is poorly processed to its mature form and exhibits decreased signaling activity (Jiang 2011). Based on available information, this variant is considered to be likely pathogenic. References: Jiang S et al. Mendenhall syndrome - phenotypic heterogeneity of insulin receptor gene mutations. Endocr J. 2011;58(11):931-40. Rique S et al. Identification of three novel mutations in the insulin receptor gene in type A insulin resistant patients. Clin Genet. 2000 Jan;57(1):67-9.

OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 11, 2021

Support Center